๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I trial of a 72-h continuous-infusion schedule of fazarabine

โœ Scribed by Robert Amato; Dah Ho; Sue Schmidt; Irwin H. Krakoff; Martin Raber

Publisher
Springer
Year
1992
Tongue
English
Weight
346 KB
Volume
30
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A Phase I trial of spirogermanium admini
A Phase I trial of spirogermanium administered on a continuous infusion schedule
โœ Paul V. Woolley; James D. Ahlgren; Patrick J. Byrne; Victor M. Priego; Philip S. ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer US ๐ŸŒ English โš– 328 KB

We have evaluated the toxicity of the antitumor agent spirogermanium on a schedule of continuous intravenous administration for periods up to five days. The doses tested were between 100 mg/m 2/day and 500 mg/m 2/day. Peripheral vein phlebitis occurred at all dose levels and was not relieved by addi

A phase I trial of continuous infusion c
A phase I trial of continuous infusion cisplatin
โœ Marshall R. Posner; Laura Ferrari; James F. Belliveau; Francis J. Cummings; Mich ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 427 KB ๐Ÿ‘ 2 views
Phase-I trial of combination therapy wit
Phase-I trial of combination therapy with continuous-infusion MMPR and continuous-infusion 5-FU
โœ William P. Peters; Geoffrey Weiss; Donald W. Kufe ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 301 KB

Fourty-four evaluable patients were treated with 6-methylmercaptopurine riboside (MMPR) at a dose of 20 mg/m2/day X 5 by continuous IV infusion (days 1-5 and 5-fluorouracil (5-FU) on an escalating dose schedule of 300-1519 mg/m2/day X 5 by continuous IV infusion (days 2-6). Dose-limiting oral mucosi